Persistent sexual dysfunction after discontinuation of selective serotonin reuptake inhibitors.

@article{Csoka2008PersistentSD,
  title={Persistent sexual dysfunction after discontinuation of selective serotonin reuptake inhibitors.},
  author={Antonei B Csoka and Audrey S. Bahrick and O P Mehtonen},
  journal={The journal of sexual medicine},
  year={2008},
  volume={5 1},
  pages={
          227-33
        }
}
INTRODUCTION Sexual dysfunctions such as low libido, anorgasmia, genital anesthesia, and erectile dysfunction are very common in patients taking selective serotonin reuptake inhibitors (SSRIs). It has been assumed that these side effects always resolve after discontinuing treatment, but recently, four cases were presented in which sexual function did not return to baseline. Here, we describe three more cases. Case #1: A 29-year-old with apparently permanent erectile dysfunction after taking… Expand
Sexual Consequences of Post-SSRI Syndrome.
  • Y. Reisman
  • Medicine, Psychology
  • Sexual medicine reviews
  • 2017
TLDR
The data support the existence of post-SSRI sexual dysfunctions, which can have a substantial effect on the quality of life of these patients and more research is warranted to show the cause and possible mechanisms of PSSD that could lead to the correct diagnosis and treatment. Expand
Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction: Current Management Perspectives
  • M. Atmaca
  • Medicine
  • Neuropsychiatric disease and treatment
  • 2020
TLDR
SSRI-induced sexual dysfunction and new perspectives in the management of this problem were reviewed and it was reported that one in eight people have utilized one of the SSRIs in the past 10 years. Expand
Post-SSRI Sexual Dysfunction: A Literature Review.
TLDR
PSSD is a debilitating condition that adversely affects quality of life and many strategies have been suggested and tried, including serotonergic antagonists and dopaminergic agonists, but there is still no definitive treatment for PSSD. Expand
Post-finasteride syndrome and post-SSRI sexual dysfunction: two sides of the same coin?
TLDR
The present review will report the state of art of these two different pathologies and discuss, on the basis of the role exerted by three different neuromodulators such as dopamine, serotonin and neuroactive steroids, whether the persistent sexual dysfunction observed could be determined by common mechanisms. Expand
Persistence of Sexual Dysfunction Side Effects after Discontinuation of Antidepressant Medications: Emerging Evidence
Post-market prevalence studies have found that Selective Serotonin Reuptake Inhibitor (SSRI) and Serotonin- Norepinephrine Reuptake Inhibitor (SNRI) sexual side effects occur at dramatically higherExpand
Post-SSRI Sexual Dysfunction: Preclinical to Clinical. Is It Fact or Fiction?
TLDR
There is some preclinical evidence from animal studies for enduring SSRI-induced sexual dysfunction, but the available clinical information could prevent a clear decision about the existence of post-SSRI sexual dysfunction. Expand
Post-SSRI Sexual Dysfunction: Clinical Characterization and Preliminary Assessment of Contributory Factors and Dose-Response Relationship
TLDR
The findings add to previous reports and support the existence of PSSD, which may not be fully explained by alternative nonpharmacological factors related to sexual dysfunction, including depression and anxiety. Expand
The effects of citalopram and fluoxetine on sexual behavior in healthy men: evidence of delayed ejaculation and unaffected sexual desire. A randomized, placebo-controlled, double-blind, double-dummy, parallel group study.
TLDR
Citalopram and fluoxetine did not directly affect penile erection as objectively assessed by RigiScan, although an impairment in the subjective assessment of erectile function was observed, and it was thought to be a possible consequence of the delayed ejaculation perceived as a trouble. Expand
Persistent sexual dysfunction after early exposure to SSRIs: Systematic review of animal studies.
TLDR
The results showed substantial and lasting effects on sexual behaviour in rats after exposure to an SSRI early in life on important sexual outcomes. Expand
Exposure to serotonin selective reuptake inhibitors or serotonin noradrenaline reuptake inhibitors and sexual dysfunction: Results from an online survey.
TLDR
Different variables, represented by both emotional and sexual symptoms, accounted for the variability of the severity of the sexual dysfunction as well as of wellbeing. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 41 REFERENCES
Persistent Sexual Side Effects after SSRI Discontinuation
TLDR
A 30-year-old male was prescribed 50 mg q.d. sertraline for chronic depression and insomnia in 1999 and noticed a severe drop in sexual desire, moderate erectile dysfunction, reaching orgasm with a long refractory time, reduced ejaculate volume, and genital numbness. Expand
Genital Anaesthesia Persisting Six Years after Sertraline Discontinuation
TLDR
A 26-year-old male who experienced genital anaesthesia during sertraline treatment and continued to be symptomatic despite medication discontinuation 6 years previously is reported, highlighting the complex interplay of psychopharmacologic and psychodynamic factors that can occur in patients with sexual dysfunction. Expand
Effects of SSRIs on sexual function: a critical review.
TLDR
The effects of SSRIs on sexual functioning seem strongly dose-related and may vary among the group according to serotonin and dopamine reuptake mechanisms, induction of prolactin release, anticholinergic effects, inhibition of nitric oxide synthetase, and propensity for accumulation over time. Expand
Premature Ejaculation Associated with Citalopram Withdrawal
TLDR
This is the first report, to the authors' knowledge, of the emergence of sexual adverse effects in someone with no previous history of these symptoms, andPremature ejaculation is a possible withdrawal effect after SSRI discontinuation. Expand
SSRI-associated sexual dysfunction.
  • R. Balon
  • Medicine
  • The American journal of psychiatry
  • 2006
TLDR
A 35-year-old woman referred by her therapist for an evaluation of her sadness, irritability, fatigue, and poor concentration over a period of two and a half years, which did not improve significantly during the course of cognitive behavior therapy, revealed a lack of sexual desire and difficulty in achieving orgasm. Expand
Mechanisms and treatments of SSRI-induced sexual dysfunction.
TLDR
SSRI-induced sexual dysfunction affects 30% to 50% or more of individuals who take these drugs for depression, and five approaches to treatment include conservative approaches such as wait and see, decrease dosage, and drug holidays. Expand
Burden of phase-specific sexual dysfunction with SSRIs.
TLDR
Dysfunction in at least one phase of the sexual response cycle is very common and may reduce sexual health-related quality of life among patients who do not experience clinically significant global sexual dysfunction on SSRI/SNRI monotherapy. Expand
"Dopamine-dependent" side effects of selective serotonin reuptake inhibitors: a clinical review.
TLDR
The relationships between changes in dopaminergic neurotransmission induced by SSRIs and the occurrence of certain side effects such as hyperprolactinemia, extrapyramidal symptoms, sexual and cognitive dysfunction, galactorrhea, mammary hypertrophy, and, more rarely, gynecomastia are highlighted. Expand
Persistent genital arousal in women – a new syndrome entity
The persistent sexual arousal syndrome (PSAS) is a newly described entity where women become involuntarily aroused genitally for extended periods in time in the absence of sexual desire. GenitalExpand
Oxytocin involvement in SSRI-induced delayed ejaculation: a review of animal studies.
TLDR
Preliminary data suggest that the severity of chronic SSRI treatment-induced delayed ejaculation and the differences between the various SSRIs in inducing ejaculation delay is related to gradual desensitization of 5-HT(1A) receptors on oxytocin neurons. Expand
...
1
2
3
4
5
...